Frankfurt-am-Main, Germany

Christoph Hartmann


 

 

Average Co-Inventor Count = 8.4

ph-index = 1

Forward Citations = 3(Granted Patents)


Company Filing History:


Years Active: 2019-2025

Loading Chart...
Loading Chart...
Loading Chart...
4 patents (USPTO):Explore Patents

Title: Christoph Hartmann: Innovator in Cancer Research

Introduction

Christoph Hartmann is a significant figure in the field of cancer research, based in Frankfurt-am-Main, Germany. He has been instrumental in advancing medical technology, contributing to the understanding and treatment of various types of cancer through his innovative work. With three patents to his name, Hartmann's inventions focus on tumor antigens and methods for cancer diagnosis and treatment.

Latest Patents

His most recent patents include groundbreaking developments in tumor antigens for determining cancer therapy, particularly targeting breast cancer, including triple-negative breast cancer. This invention outlines methods and compositions that utilize specific tumor antigens to enhance cancer treatment. Additionally, his patent concerning methods and compositions for the diagnosis and treatment of cancer identifies nucleic acid and amino acid sequences characteristic of tumor tissues, which serve as potential targets for therapy or diagnosis of central nervous system tumors, such as gliomas and glioblastomas.

Career Highlights

Throughout his career, Christoph Hartmann has collaborated with leading companies in the pharmaceutical and biomedical sectors. Notably, he has worked with BioNTech AG, a pioneering company known for its contributions to cancer immunotherapy. He has also been associated with Translational Oncology at the University Medical Center Mainz, further solidifying his role in advancing research in oncology.

Collaborations

Hartmann's collaborative spirit has led him to work alongside distinguished colleagues, including Ugur Sahin and Claudia Paret. These collaborations have been critical in driving innovative solutions and translating scientific discoveries into applicable therapies for cancer patients.

Conclusion

In summary, Christoph Hartmann's contributions to cancer research through his patented innovations underscore his commitment to enhancing treatment methods and diagnostic capabilities for various cancers. His work demonstrates the vital intersection of research and practical application in the ongoing fight against cancer, positioning him as an influential innovator in the field.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…